Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog
Chemistry – An Asian Journal · 2026-07 · 21 (13)
DOI: 10.1002/asia.70863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 06.07.2026. Verfasst von Kato Bredael und 5 weiteren Autor:innen. Beteiligte Einrichtung: SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Cephalosporins, Anti-Bacterial Agents. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Ghent University, FWO, Research Foundation-Flanders.
Abstract (Originalsprache)
Antimicrobial resistance is a major and growing global health challenge, necessitating the development of novel antibacterial agents. Previous in‐house research identified monocyclic α‐benzylidene‐substituted 3‐amino‐1‐carboxymethyl‐β‐lactams as promising hit scaffolds due to their potential to inhibit penicillin‐binding proteins (PBPs). In this study, a new ceftobiprole analog was designed by combining the characteristic α‐alkylidene fragment from this hit scaffold with the ceftobiprole vinylpyrrolidinone side chain selected for its favorable pharmacological properties. The target structure was synthesized via a modular approach, employing two Wittig reactions as key steps. Biochemical evaluation revealed that the ethyl ester derivative exhibited significant inhibition of S. pneumoniae PBP1b, highlighting this new framework as a valuable starting point for further optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
ORCID-Profile: Kato Bredael, Martina Hrast Rambaher, Matthias D'hooghe
Förderung
- Ghent University, FWO
- Research Foundation-Flanders
Zitieren
APA
Bredael, K., Hrast Rambaher, M., Decuyper, L., Magdalenic, K., Gobec, S., & D'hooghe, M. (2026). Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog. Chemistry – An Asian Journal, 21(13). https://doi.org/10.1002/asia.70863
Vancouver
Bredael K, Hrast Rambaher M, Decuyper L, Magdalenic K, Gobec S, D'hooghe M. Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog. Chemistry – An Asian Journal. 2026;21(13). doi:10.1002/asia.70863
BibTeX
@article{Bredael2026,
author = {Bredael, Kato and Hrast Rambaher, Martina and Decuyper, Lena and Magdalenic, Katarina and Gobec, Stanislav and D'hooghe, Matthias},
title = {Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog},
journal = {Chemistry – An Asian Journal},
year = {2026},
volume = {21},
number = {13},
doi = {10.1002/asia.70863}
}
EUVIMED